Stocks / LLY
LLY stock forecast
ELI LILLY & CO · Healthcare · Drug Manufacturers - General
The model's rating
Underperform
LLY is rated Underperform as of September 29, 2026: its medium-term return forecast is below the middle of the stocks the model scores, but above the bottom fifth.
Create a free account to compare any two stocks; the numeric score is part of Premium.
LLY is not among the 20 largest holdings published for 2026 Q4. See the portfolio
LLY against the S&P 500
| Period | LLY | S&P 500 (SPY) |
|---|---|---|
| 1 month | +0.0% | -0.3% |
| 3 months | -2.8% | +2.5% |
| Year to date | +8.2% | +12.7% |
| 1 year | +52.6% | +15.7% |
Total return, dividends included.
Key numbers
| Price | $1,157.08 |
| Market cap | 1.09 Trillion |
| P/E (trailing 12 months) | 38.8 |
| P/S (trailing 12 months) | 13.7 |
| P/B (latest quarter) | 32.5 |
| Gross margin | 83.4% |
| Net profit margin | 33.5% |
| Return on equity | 92.6% |
| Beta | 0.3 |
As of August 5, 2026.
LLY and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | 638.0 Billion | Outperform | LLY vs JNJ |
| ABBV | ABBVIE INC | 462.26 Billion | Outperform | LLY vs ABBV |
| MRK | MERCK & CO INC | 358.5 Billion | Greatly Outperform | LLY vs MRK |
| AMGN | AMGEN INC | 227.88 Billion | Outperform | |
| GILD | GILEAD SCIENCES INC | 184.82 Billion | Outperform | |
| PFE | PFIZER INC | 162.55 Billion | Greatly Outperform |
Questions
What does the Upfront Investment model say about LLY?
The model rates ELI LILLY & CO (LLY) "Underperform" as of September 29, 2026, which means its medium-term return forecast is below the middle of the stocks the model scores, but above the bottom fifth. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the LLY rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is LLY in the Upfront Investment model portfolio?
LLY is not among the 20 largest holdings published for 2026 Q4.
The rating is the output of a statistical model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.